Commercial Channels

How pharma’s retooling of its promotional efforts in the post-pandemic era impacts sizing and targeting, two crucial foundational pieces to successful commercialization

Arthrex to receive US rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sports medicine

A conversation with Vin Colicchio, vice president, supply chain and external manufacturing, Dr. Reddy’s Laboratories

A well-oiled, data-driven hub program is critical for stakeholders in supporting patients—and clearing a successful path for specialty therapies

A conversation with Cathy Traz, global advocacy head at Bristol Myers Squibb

Covid-19 reveals how important field reps will be to driving digital adoption

Embracing AI 2.0 and modern machine learning as foundational tools to deepening HCP engagement

Using technology to enable processes, drive cost savings, and deliver better patient outcomes

Are regulations hindering pharma innovations?

Five ways to adapt manufacturer-sponsored programs

Embracing digital channels and patient-centric strategies has been critical for commercial teams; a review of what some companies have done right

It marks the first time that two accrediting organizations with deeming authority from CMS have merged

Plan is to expand capabilities across the drug commercialization process

EnlivenHealth, formerly Population Health Solutions, targets better patient outcomes through advanced technology

'Contextual' AI blends human expertise and computer power

A modularized approach will enable pharma marketers to grow patient starts and improve adherence

Proteus Digital Health, a pioneer, crashes and burns, while EtectRx appoints a new CEO

More complex sales cycles, combined with more digitization of the sales process, calls for better engagement tools

Addressing continued hurdles in patient adherence

Company will invest $1 billion to open 500-700 clinics at its pharmacies over five years

Ed Schoonveld’s compilation on pricing strategies gets updated for the 2020s

Biopharma companies are investing in field reimbursement staff to reduce patient barriers to therapy by guiding prescribing physicians through specialty therapy access and adherence challenges

Company pitches a mfr-payer-provider-patient collaboration for drug pricing

Trinity Life Sciences offers a way to measure changing physician practices during the pandemic

Extension of the company’s Pathways program seeks to offer a richer and deeper patient interaction